Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01296841
Recruitment Status : Completed
First Posted : February 16, 2011
Results First Posted : February 7, 2013
Last Update Posted : March 3, 2017
Sponsor:
Information provided by (Responsible Party):
Roy Soetikno, VA Palo Alto Health Care System

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The investigators hypothesize that outpatient clinical care of Inflammatory Bowel Disease patients may be provided using a new computerized system over standard network - called Collaborative Imaging - with similar patient experience compared to a conventional clinic visit.

Condition or disease Intervention/treatment Phase
Inflammatory Bowel Disease Ulcerative Colitis Crohn's Disease Device: Collaborative Imaging Phase 2

Detailed Description:

Significant advances in gastroenterology have led the field to grow into a number of advanced subspecialties: inflammatory bowel disease (IBD), motility, therapeutic endoscopy, and transplant hepatology. Telemedicine, the application of information technology in support of health care delivery from a distance, has been employed with good success in various chronic conditions with excellent patient satisfaction.

Primary Aim: Our primary study endpoint was measuring patient clinical experience between two groups: A telemedicine remote clinic visit and a standard "in-house" visit.

Secondary Aim: To compare standard clinic metrics including clinic wait time, patient throughput, and appointment time between the two groups.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Randomized Controlled Pilot: Use of Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care
Study Start Date : October 2009
Actual Primary Completion Date : June 2010
Actual Study Completion Date : June 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Telehealth

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
No Intervention: Standard encounter
Standard "in-house" clinical visit between patient and physician.
Experimental: Telemedicine Encounter
Remote clinical appointment between patient and physician.
 Device: Collaborative Imaging
Hardware and software communication tools to provide clinical care from a distance.
Other Name: Telemedicine


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Patient Clinical Experience [ Time Frame: Clinic Visit ]
    We used a validated Ware Specific Visit Questionnaire to assess patients' satisfaction with their clinic-visit encounter. This is a 14-item questionnaire on doctor-patient interaction including factors such as attention to complaints, technical skills, and personal manner (courtesy,and ease of appointment scheduling and is based on a five-point Likert scale (1 excellent to 5 poor). Patients completed the questionnaire at the time of the visit. The 14 item scores were individually scored and then averaged to provide the final overall value.


Secondary Outcome Measures :
  1. Clinic Appointment Duration [ Time Frame: Clinic Visit ]
    The investigators recorded appointment duration in minutes.

  2. Clinic Appointment Wait Time [ Time Frame: Clinic Visit ]
    The investigators recorded clinic appointment wait time duration in minutes


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult (> 18 years old) outpatient IBD patients in the Veterans Affairs medical system

Exclusion Criteria:

  • VA patients without IBD
  • Hospitalized IBD patients
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01296841


Locations
Layout table for location information
United States, California
Veterans Affairs Palo Alto
Palo Alto, California, United States, 94304
Sponsors and Collaborators
VA Palo Alto Health Care System
Investigators
Layout table for investigator information
Principal Investigator: Tonya Kaltenbach, MD MS VA Palo Alto Health Care System
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Additional Information:

Publications:

Layout table for additonal information
Responsible Party: Roy Soetikno, Clinical Professor, Chief of Endoscopy, VA Palo Alto Health Care System
ClinicalTrials.gov Identifier: NCT01296841    
Other Study ID Numbers: TELEMED PA
First Posted: February 16, 2011    Key Record Dates
Results First Posted: February 7, 2013
Last Update Posted: March 3, 2017
Last Verified: January 2017
Keywords provided by Roy Soetikno, VA Palo Alto Health Care System:
telemedicine
remote consultation
telehealth
 ehealth
image archiving
inflammatory bowel disease
Additional relevant MeSH terms:
Layout table for MeSH terms
Crohn Disease
Intestinal Diseases
Inflammatory Bowel Diseases
 Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases